이엔셀, 6억 규모 첨단바이오의약품 제조 공급 계약 체결

ENCell's new contract underscores the increasing reliance on specialized CDMO services for advanced biopharmaceutical development, securing a revenue stream equivalent to 11% of its annual sales. This deal validates ENCell's domestic manufacturing infrastructure and its strategic role in supporting clinical-stage biotech companies through complex production processes.